BM
BMY
Market ClosedBristol-Myers Squibb Company
US
32.50K employees
CEO: Christopher Boerner
Founded: 1972
$66.82
+$0.00(+NaN%)
Market Cap
136.49B
Beta
0.23
52W Range
N/A
Dividend Yield
3.76%
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
71.1%
24.9%
CAGR: 6.4%
Profit after direct costs
Operating Margin
28.5%
42.1%
CAGR: 9.5%
Core business profitability
Net Margin
14.6%
-178.8%
CAGR: 0.2%
Bottom line profitability
Revenue Growth
-0.2%
YoY
CAGR: 1.0%
Top line growth rate
Revenue Flow Analysis
Visual flow showing how BMY allocates revenue across expenses and profit
Fiscal Year 2025
Revenue Distribution
Flow of revenue through cost categories to net income
Gross Margin
71.1%
$34.26B
Operating Margin
28.5%
$13.72B
Net Margin
14.6%
$7.05B
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 46.38B | 46.16B | 45.01B | 48.30B | 48.20B | -0.2% | |
| Cost of Revenue | (19.62B) | (19.67B) | (19.65B) | (20.87B) | (13.94B) | -33.2% | |
Gross Profit | 26.76B | 26.49B | 25.36B | 27.43B | 34.26B | 24.9% | |
| Operating Expenses | |||||||
| Research & Development | (9.53B) | (9.41B) | (9.21B) | (9.78B) | (9.95B) | 1.7% | |
| Selling, General & Administrative | (7.69B) | (7.81B) | (7.68B) | (7.87B) | (7.27B) | -7.6% | |
| Depreciation & Amortization | (10.69B) | (10.28B) | (9.76B) | (9.60B) | (4.01B) | -58.2% | |
Operating Income (EBIT) | 9.54B | 9.27B | 8.47B | 9.66B | 13.72B | 42.1% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (1.33B) | (1.23B) | (1.17B) | (1.95B) | (1.89B) | -2.9% | |
| Other Income/Expenses (Net) | -1.44B | -1.56B | -32.00M | -18.04B | -4.40B | -75.6% | |
Income Before Tax | 8.10B | 7.71B | 8.44B | -8.38B | 9.33B | -211.3% | |
| Income Tax Expense | (1.08B) | (1.37B) | (400.00M) | (554.00M) | (2.27B) | 310.1% | |
Net Income | 6.99B | 6.33B | 8.03B | -8.95B | 7.05B | -178.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $3 | $3 | $4 | $-4 | $3 | -178.5% | |
| Weighted Avg Shares Outstanding | 2.22B | 2.13B | 2.07B | 2.03B | 2.04B | 0.7% | |
| Weighted Avg Shares Outstanding (Diluted) | 2.25B | 2.15B | 2.08B | 2.03B | 2.04B | 0.7% | |
EBITDA | 20.12B | 19.22B | 19.37B | 3.17B | 15.23B | 380.7% |
Explore BMY
BMY in the Healthcare
Large Cap